Vyome Holdings acquires MIT spinout Oculo Health and launches a new business unit to develop an AI psychiatrist focused on treating systemic inflammation.
Read MoreVyome Holdings
Vyome and Embryyo Sign MoU to Develop AI-Enabled Medical Devices
Vyome and Embryyo sign MoU to jointly develop AI-enabled medical devices, aiming to transform healthcare innovation across the U.S.-India corridor.
Read More
Vyome Therapeutics Completes Merger with ReShape Lifesciences; Nasdaq Debut Under Ticker HIND
Vyome Therapeutics completes merger with ReShape Lifesciences; to trade on Nasdaq as Vyome Holdings (HIND) from August 15, 2025.
Read More